Zhang Xuekang, Hu Qian, Liu Zhiyi, Huang Haijin, Zhang Qin, Dai Hanying
Department of Anesthesiology, First Affiliated Hospital of Nanchang University Jiangxi, China.
Grade 2014 of Medical Department of Graduate School, Nanchang University Jiangxi, China.
Int J Clin Exp Med. 2015 Oct 15;8(10):19353-9. eCollection 2015.
Allogenetic transfusion has long been considered to be a relatively safe and extremely effective blood transfusion treatment. However, acute hypervolemic hemodilution (AHH) combined with the remifentanil-induced controlled hypotension (CH) have rarely been examined. Herein, 40 intracranial aneurysm surgery patients were randomly divided into nitroglycerin group (A group, n=20) and remifentanil group (B group, n=20). During intracranial aneurysm surgery, MAP, HR, Hb, and Hct were recorded. SjvO2, PjvO2, SaO2, PaO2 were measured, and CaO2, Da-jvO2, CjvO2, CERO2, VADL were calculated. In addition, The venous blood samples were collected for determining PT, TT, APTT, FBG, VIII, VWF and electrolytes. The results show that HR in nitroglycerin group dramatically accelerated and HR in remifentanil group slowed at 30 minutes after hypotension and 5 minutes after aneurysm occlusion (P<0.01) after hypotension. Compared with A group, the SjvO2 and CjvO2 of B group increased significantly and the Da-jvO2 and CERO2 decreased significantly at T3, T4. In addition, There were no significant differences between after AHH and before AHH in two groups (P>0.05) on TT, PT, APTT, FIB, VIII, VWF, Na(+), Cl(-), K(+), Ca(2+). These results suggest that AHH combined with remifentanil-based CH significantly lowered cerebral metabolic rate of oxygen and had effects on blood coagulation without clinical hemorrhagic signs increased and had important clinical significance for blood conservation.
异体输血长期以来一直被认为是一种相对安全且极其有效的输血治疗方法。然而,急性高容量血液稀释(AHH)联合瑞芬太尼诱导的控制性低血压(CH)的情况却鲜有研究。在此,将40例颅内动脉瘤手术患者随机分为硝酸甘油组(A组,n = 20)和瑞芬太尼组(B组,n = 20)。在颅内动脉瘤手术期间,记录平均动脉压(MAP)、心率(HR)、血红蛋白(Hb)和血细胞比容(Hct)。测量颈静脉血氧饱和度(SjvO2)、颈静脉血氧分压(PjvO2)、动脉血氧饱和度(SaO2)、动脉血氧分压(PaO2),并计算动脉血氧含量(CaO2)、颈静脉 - 动脉血氧含量差(Da - jvO2)、颈静脉血氧含量(CjvO2)、脑氧摄取率(CERO2)、脑氧代谢率(VADL)。此外,采集静脉血样以测定凝血酶原时间(PT)、凝血酶时间(TT)、活化部分凝血活酶时间(APTT)、纤维蛋白原(FBG)、因子Ⅷ(VIII)、血管性血友病因子(VWF)和电解质。结果显示,低血压后30分钟及动脉瘤夹闭后5分钟时,硝酸甘油组的心率显著加快,瑞芬太尼组的心率减慢(低血压后P<0.01)。与A组相比,B组在T3、T4时SjvO2和CjvO2显著升高,Da - jvO2和CERO2显著降低。此外,两组在急性高容量血液稀释后与稀释前相比,TT、PT、APTT、纤维蛋白原(FIB)、VIII、VWF、钠离子(Na(+))、氯离子(Cl(-))、钾离子(K(+))、钙离子(Ca(2+))方面均无显著差异(P>0.05)。这些结果表明,急性高容量血液稀释联合基于瑞芬太尼的控制性低血压可显著降低脑氧代谢率,对凝血有影响但未增加临床出血征象,对血液保护具有重要临床意义。